Clinical Trial Update: POF Versus FOLFOX Plus IP Paclitaxel in AGC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing POF regimen versus FOLFOX plus IP paclitaxel in advanced gastric cancer is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• FOLFOX
• IP paclitaxel (paclitaxel)
• POF

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN